Journal of Clinical Oncology, Vol 9, 539-547, Copyright © 1991 by American Society of Clinical Oncology

ARTICLES

Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma

JP Greer, MC Kinney, RD Collins, KE Salhany, SN Wolff, JD Hainsworth, JM Flexner and RS Stein
Department of Medicine, Vanderbilt University, Nashville, TN.

Thirty-one patients were diagnosed by morphologic and immunophenotypic features as having primary Ki-1 anaplastic large-cell lymphoma (Ki-1 ALCL). the median age was 35 years (range, 4 months to 78 years); the male:female ratio was 18:13. B symptoms were observed in 13 patients. Peripheral adenopathy was present in 26 patients, while mediastinal adenopathy occurred in five. There was extranodal disease in 13 patients; the most common extranodal site was skin with seven affected. Seventeen patients had stage III/IV disease. Immunophenotypes were T cell in 24 patients and B cell in four patients; immunophenotype could not be determined in three patients. Cytogenetic abnormalities in chromosomes 2, 5, and 7 were detected in three patients. Although therapy was heterogeneous, the actuarial 2-year survival was 73%. Two- year disease-free survival was 39% for all patients; for stages I and II, it was 62% compared with 20% for stages III and IV (P = .001). Complete remission (CR) occurred in 21 of 23 patients receiving combination chemotherapy; however, nine relapses, including six of seven stage IV patients, occurred within 21 months of diagnosis. Preliminary observations suggest that Ki-1 ALCL may have a quiescent phase in the rare patient with only localized skin disease. However, the disease generally behaves as an intermediate- to high-grade lymphoma, and patients with Ki-1 ALCL should receive curative-intent combination chemotherapy.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S.-J. Wu, M. Yao, H.-F. Tien, J.-L. Tang, C.-W. Lin, and Y.-C. Chen Anaplastic Large Cell Lymphoma in Leukemic Transformation: Successful Treatment by Transplantation J. Clin. Oncol., October 1, 2007; 25(28): 4490 - 4492. [Full Text] [PDF]

				E. Jacobsen Anaplastic Large-Cell Lymphoma, T-/Null-Cell Type Oncologist, July 1, 2006; 11(7): 831 - 840. [Abstract] [Full Text] [PDF]

				S A Pileri, S Ascani, L Leoncini, E Sabattini, P L Zinzani, P P Piccaluga, A Pileri Jr, M Giunti, B Falini, G B Bolis, et al. Hodgkin's lymphoma: the pathologist's viewpoint J. Clin. Pathol., March 1, 2002; 55(3): 162 - 176. [Abstract] [Full Text] [PDF]

				S. J. Meech, L. McGavran, L. F. Odom, X. Liang, L. Meltesen, J. Gump, Q. Wei, S. Carlsen, and S. P. Hunger Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4-anaplastic lymphoma kinase gene fusion Blood, August 15, 2001; 98(4): 1209 - 1216. [Abstract] [Full Text] [PDF]

				A. H. Sarris, I. Braunschweig, L. J. Medeiros, M. Duvic, C. S. Ha, M. A. Rodriguez, F. B. Hagemeister, P. McLaughlin, J. Romaguera, J. Cox, et al. Primary Cutaneous Non-Hodgkin's Lymphoma of Ann Arbor Stage I: Preferential Cutaneous Relapses but High Cure Rate With Doxorubicin-Based Therapy J. Clin. Oncol., January 15, 2001; 19(2): 398 - 405. [Abstract] [Full Text] [PDF]

				J. P. Greer, M. C. Kinney, and T. P. Loughran Jr. T Cell and NK Cell Lymphoproliferative Disorders Hematology, January 1, 2001; 2001(1): 259 - 281. [Abstract] [Full Text] [PDF]

				D. O. Yanase, P. S. Vogel, and K. E. Warschaw Red Nodules on the Arm of a Patient With Breast Cancer Arch Dermatol, December 1, 2000; 136(12): 1559 - 1564. [Full Text] [PDF]

				R. D. Gascoyne, P. Aoun, D. Wu, M. Chhanabhai, B. F. Skinnider, T. C. Greiner, S. W. Morris, J. M. Connors, J. M. Vose, D. S. Viswanatha, et al. Prognostic Significance of Anaplastic Lymphoma Kinase (ALK) Protein Expression in Adults With Anaplastic Large Cell Lymphoma Blood, June 1, 1999; 93(11): 3913 - 3921. [Abstract] [Full Text] [PDF]

				B. Falini, S. Pileri, P. L. Zinzani, A. Carbone, V. Zagonel, C. Wolf-Peeters, G. Verhoef, F. Menestrina, G. Todeschini, M. Paulli, et al. ALK+ Lymphoma: Clinico-Pathological Findings and Outcome Blood, April 15, 1999; 93(8): 2697 - 2706. [Abstract] [Full Text] [PDF]

				L. Brugieres, M.C. L. Deley, H. Pacquement, Z. Meguerian-Bedoyan, M.J. Terrier-Lacombe, A. Robert, C. Pondarre, G. Leverger, C. Devalck, C. Rodary, et al. CD30+ Anaplastic Large-Cell Lymphoma in Children: Analysis of 82 Patients Enrolled in Two Consecutive Studies of the French Society of Pediatric Oncology Blood, November 15, 1998; 92(10): 3591 - 3598. [Abstract] [Full Text] [PDF]

				P. L. Zinzani, M. Martelli, M. Magagnoli, A. Zaccaria, F. Ronconi, M. Cantonetti, M. Bocchia, R. Marra, M. Gobbi, B. Falini, et al. Anaplastic Large Cell Lymphoma Hodgkin's-Like: A Randomized Trial of ABVD Versus MACOP-B With and Without Radiation Therapy Blood, August 1, 1998; 92(3): 790 - 794. [Abstract] [Full Text] [PDF]

				F. Falcini, M. Bardare, R. Cimaz, A. Lippi, and F. Corona Arthritis as a presenting feature of non-Hodgkin's lymphoma Arch. Dis. Child., April 1, 1998; 78(4): 367 - 370. [Abstract] [Full Text]

				H. Tilly, P. Gaulard, E. Lepage, C. Dumontet, J. Diebold, I. Plantier, F. Berger, M. Symann, T. Petrella, P. Lederlin, et al. Primary Anaplastic Large-Cell Lymphoma in Adults: Clinical Presentation, Immunophenotype, and Outcome Blood, November 1, 1997; 90(9): 3727 - 3734. [Abstract] [Full Text] [PDF]

				M. U. Kuefer, A. T. Look, K. Pulford, F. G. Behm, P. K. Pattengale, D. Y. Mason, and S. W. Morris Retrovirus-Mediated Gene Transfer of NPM-ALK Causes Lymphoid Malignancy in Mice Blood, October 15, 1997; 90(8): 2901 - 2910. [Abstract] [Full Text] [PDF]

				The Non-Hodgkin's Lymphoma Classification Project A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood, June 1, 1997; 89(11): 3909 - 3918. [Abstract] [Full Text] [PDF]

				P. Mathew, W. G. Sanger, D. D. Weisenburger, M. Valentine, V. Valentine, D. Pickering, C. Higgins, M. Hess, X. Cui, D. K. Srivastava, et al. Detection of the t(2; 5)(p23; q35) and NPM-ALK Fusion in Non-Hodgkin's Lymphoma by Two-Color Fluorescence In Situ Hybridization Blood, March 1, 1997; 89(5): 1678 - 1685. [Abstract] [Full Text] [PDF]

				D.P. Schenkein and E. Ahmed Case 29-1995- A 65-year-old man with mediastinal Hodgkin's disease and a pelvic mass N. Engl. J. Med., September 21, 1995; 333(12): 784 - 791. [Full Text] [PDF]

				S. Morris, M. Kirstein, M. Valentine, K. Dittmer, D. Shapiro, D. Saltman, and A. Look Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma Science, March 4, 1994; 263(5151): 1281 - 1284. [Abstract] [PDF]

				J. O. Armitage Treatment of Non-Hodgkin's Lymphoma N. Engl. J. Med., April 8, 1993; 328(14): 1023 - 1030. [Full Text]